Menu
QF-Pro® is currently validated for various applications and biomarkers, including:
As a versatile platform technology, QF-Pro® can be tailored to any functional protein target of interest. We work closely with clients to design and create novel functional biomarkers in a range of indications. We are constantly working to increase our off-the-shelf repertoire of biomarkers, of which you can find some examples below:
Example 1: Interaction of the immune checkpoint TIGIT/CD155 between Jurkat T cells and CHO-K1 cells.
Example 2: Activation state of Akt in clear cell renal cell carcinoma tissue.
Example 3: Interaction state of HER2/HER3 in clear cell renal cell carcinoma tissue.
Partnerships
Want to work with us? Find out about our companion diagnostics (CDx) partnership program and scientific collaborations. We have extensive collaborative networks around the world where we are running QF-Pro®-based studies.
Papers
Read our latest manuscripts to see how QF-Pro® has been used to advance translational and clinical research. Alternatively, our reviews will show you how quantitative functional proteomics can pave the way to more impactful research.
This project has been co-funded by the European Union’s Horizon Europe research and innovation programme under grant agreement Nº101161495.
“Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.”
Stay connected
Subscribe to the HAWK Biosystems newsletter and don’t miss any news about our company, our products, events and much more.